^
Association details:
Biomarker:PTEN deletion
Cancer:Gastric Cancer
Drug:MEN1611 (PI3K inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Title:

The Selective Class I PI3K Inhibitor CH5132799 Targets Human Cancers Harboring Oncogenic PIK3CA Mutations

Excerpt:
...in the PTEN-deficient model, gastric cancer GXF97 tumors in which the PTEN gene was deleted were shrunk remarkably by CH5132799 administration, and tumor growth was inhibited in a PC-3 prostate cancer model.
DOI:
10.1158/1078-0432.CCR-10-2882